ENTITY

BioVie (BIVI US)

2
Analysis
Health Care • United States
BioVie Inc. is a clinical stage biotechnology company engaged in the discovery, development and commercialization of therapies targeting life-threatening complications of liver cirrhosis. The Company's initial disease target is ascites a condition impacting people globally. BioVie is based out of the United States.
more
Company Event • 11 Nov 2026 01:00 • Upcoming
Add To Calendar

AGM 2026

Company Event • 12 Nov 2026 05:00 • Upcoming
Add To Calendar

Q1 2027

Company Event • 28 Sep 2026 20:00 • Upcoming
Add To Calendar

Proxy filing

Company Event • 23 Sep 2026 23:00 • Latest

Status update

Company Event • 15 Sep 2026 20:30

Study result

x